Dolutegravir Use at Conception Not Tied to Neural Tube Defects After All
Published: 07 July 2020
A 2018 report had suggested that HIV-positive women’s use of the drug at conception increased the rate of the rare birth defects.
Created: 07 July 2020
Last Updated: 07 July 2020